Repository logo

Infoscience

  • English
  • French
Log In
Logo EPFL, École polytechnique fédérale de Lausanne

Infoscience

  • English
  • French
Log In
  1. Home
  2. Academic and Research Output
  3. Journal articles
  4. Neuropharmacology of the mesolimbic system and associated circuits on social hierarchies
 
review article

Neuropharmacology of the mesolimbic system and associated circuits on social hierarchies

Ghosal, S.
•
Sandi, C.
•
van der Kooij, M.A.
2019
Neuropharmacology

Most socially living species are organized hierarchically, primarily based on individual differences in social dominance. Dominant individuals typically gain privileged access to important resources, such as food, mating partners and territories, whereas submissive conspecifics are often devoid of such benefits. The benefits associated with a high social status provide a strong incentive to become dominant. Importantly, motivational- and reward-related processes are regulated, to a large extent, by the mesolimbic system. Consequently, several studies point to a key role for the mesolimbic system in social hierarchy formation. This review summarizes the growing body of literature that implicates the mesolimbic system, and associated neural circuits, on social hierarchies. In particular, we discuss the neurochemical and pharmacological studies that have highlighted the contributions of the mesolimbic system and associated circuits including dopamine signaling through the D1 or D2 receptors, GABAergic neurotransmission, the androgen receptor system, and mitochondria and bioenergetics. Given that low social status has been linked to the emergence of anxiety- and depressive-like disorders, a greater understanding of the neurochemistry underlying social dominance could be of tremendous benefit for the development of pharmacological treatments to dysfunctions in social behaviors.

  • Files
  • Details
  • Metrics
Type
review article
DOI
10.1016/j.neuropharm.2019.01.013
Author(s)
Ghosal, S.
Sandi, C.
van der Kooij, M.A.
Date Issued

2019

Published in
Neuropharmacology
Volume

159

Article Number

107498

Editorial or Peer reviewed

REVIEWED

Written at

EPFL

EPFL units
LGC  
FunderGrant Number

EU funding

587566

FNS-NCCR

158776

FNS

176206

Available on Infoscience
November 15, 2020
Use this identifier to reference this record
https://infoscience.epfl.ch/handle/20.500.14299/154343
Logo EPFL, École polytechnique fédérale de Lausanne
  • Contact
  • infoscience@epfl.ch

  • Follow us on Facebook
  • Follow us on Instagram
  • Follow us on LinkedIn
  • Follow us on X
  • Follow us on Youtube
AccessibilityLegal noticePrivacy policyCookie settingsEnd User AgreementGet helpFeedback

Infoscience is a service managed and provided by the Library and IT Services of EPFL. © EPFL, tous droits réservés